News
Granite Awarded $32 Million Highway Realignment in California
Granite (NYSE:GVA) has been selected for the State Route 20 Omega Curve Realignment project in Nevada County, California. The project is awarded by Caltrans and funded by State and Federal aid. The
Guess?, Inc. to Webcast Conference Call to Announce Its Fourth Quarter and Fiscal Year 2022 Financial Results
Guess?, Inc. (NYSE: GES) will release its financial results for the fourth quarter and fiscal year 2022, which ended January 29, 2022, on Wednesday, March 16, 2022. The Company will webcast a
The First Bancshares, Inc. Announces New Share Repurchase Plan
The First Bancshares, Inc. (NASDAQ: FBMS) (“First Bancshares” or the “Company”), the holding company for The First Bank, announced today that the Company’s board of directors has approved a new
GeoPark Announces CEO Succession and Management Transition Plan
The Board of Directors of GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), is pleased to announce the implementation of its long-planned succession process and that, after twenty years at
GeoPark Announces Doubling Its Quarterly Cash Dividend to $0.082 Per Share
GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent Latin American oil and gas explorer, operator and consolidator, announces that its Board of Directors has declared a
GeoPark Reports Fourth Quarter and Full-Year 2021 Results
GeoPark Limited (“GeoPark” or the “Company”) (NYSE: GPRK), a leading independent Latin American oil and gas explorer, operator and consolidator, reports its consolidated financial results for the
McGrath RentCorp to Present at the Sidoti & Company, LLC Spring Virtual Small Cap Investor Conference
McGrath RentCorp (Nasdaq:MGRC), a diversified business-to-business rental company, today announced that it will participate in the Sidoti & Company, LLC Spring Virtual Small Cap Investor Conference
First Trust Global Portfolios Management Limited Announces Distributions for certain sub-funds of First Trust Global Funds plc
First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the quarterly distributions for the following sub-funds of First Trust Global Funds plc.
ISIN
Fund
Chemed Corporation to Present at the Oppenheimer 32nd Annual Healthcare Conference
Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 32nd Annual Healthcare Conference on Wednesday, March 16, 2022, at approximately 8:40
Venezuelan Ministry of Mines Revokes Mineral Rights of Siembra Minera – Gold Reserve Considering All Legal Rights and Remedies
Gold Reserve Inc. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announced that it has learned that The Ministry of Mines of Bolivarian Republic of Venezuela (“Ministry of Mines”)
State Street to Develop Digital Custody in Collaboration with Copper.co
State Street Corporation (NYSE: STT) announced today that State Street Digital, the firm’s dedicated Digital division, has entered into a licensing agreement with Copper.co, a London-based provider
Pitney Bowes and Ambi Robotics Sign $23 Million Deployment Expansion To Help Optimize Last-Mile Sorting Across US Hubs
Pitney Bowes (NYSE: PBI), a global shipping and mailing company that provides technology, logistics, and financial services and Ambi Robotics, the leader in robotic sorting systems for supply chain
Philip Morris International Inc. (PMI) Suspends Investment and Activates Plans to Scale Down Manufacturing Operations in the Russian Federation
Regulatory News:
Philip Morris International Inc. (NYSE: PM) today announces the suspension of its planned investments in the Russian Federation, including all new product launches and
Alcoa Completes Energy Infrastructure Project at Its Deschambault Smelter in Canada to Boost Aluminum Production, Improve Stability
Alcoa Corporation (NYSE: AA) today officially marked the completion of a capital project that is expected to improve stability, increase efficiency, and boost production at its Deschambault
Cortexyme Announces Preclinical Data Highlighting Potential Therapeutic Benefits of Atuzaginstat for the Treatment of High-Risk Oral Potentially Malignant Disorders
Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company pioneering upstream therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, today
IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company”) (NASDAQ: IPA) (TSXV: IPA) is pleased to report on the latest progress in the development of their PolyTope® TATX-03 antibody cocktail therapy
Savara to Present at Oppenheimer’s 32nd Annual Healthcare Conference
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at Oppenheimer’s 32nd Annual
CleanGo Innovations Inc. Is Pleased ToReport That They Have CommencedDiscussions With An EstablishedGerman Distributor
Ozon Comments on its $750 million Senior Unsecured Convertible Bonds due 2026
Ozon Holdings PLC (NASDAQ and MOEX: “OZON”, thereafter referred to as “we,” “us,” “our,” “Ozon” or the “Company”), a leading Russian e-commerce platform, provides further update on the potential
REV Group, Inc. Reports First Quarter Results and Reaffirms Fiscal 2022 Outlook
REV Group, Inc. (NYSE: REVG), a manufacturer of industry-leading specialty vehicles, today reported results for the three months ended January 31, 2022 (“first quarter 2022”). Consolidated net
Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Tucker Kelly, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Barclays Global
IMV to Showcase its DPX® Delivery Technology in Two Presentations at the AACR Annual Meeting 2022
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today
Biomind Labs Receives Approval for a Second Phase II Clinical Trial for Treatment-resistant Depression
Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: CRSWF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous tryptamines (biomolecules acting
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants
Pfizer Inc. (NYSE: PFE) announced today that it has initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease Inhibition for COVID-19 in Pediatric Patients), to evaluate the safety